Glatiramer Injection
The Framework Agreement is awarded for the supply of Glatiramer Acetate Injection in 20 mg and 40 mg presentations to Participating Authorities across NHS. Scotland. Supply will be made either directly to hospitals, patients in their own homes, or other designated delivery address, via a manufactured commissioned Home Delivery Service or to a home delivery supplier(s) as directed by the Participating Authorities and/or the Authority.
Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Value
£235,114
Published
24 Nov 2021
Closes
24 Nov 2021
Procurement details
Source
Pcs
Region
Scotland
Procurement method
Limited
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
33661000
Medicinal products for the nervous system
Lots
Lot 2 Glatiramer Acetate Injection excluding a manufacturer commissioned Home Delivery Service
£265,129
This Lot is for the supply of 20 mg and 40 mg glatiramer acetate injection direct to hospitals or nominated Home Delivery supplier(s) as directed by Participating Authorities and/or the Authority.
Delivery: Scotland
Lot 1 Glatiramer Acetate Injection including the provision of a manufacturer commissioned Home Delivery Service.
£235,114
This Lot is for the supply of 20 mg and 40 mg Glatiramer Acetate Injection direct to hospitals or direct to patients in their own home, or other designated address, via a manufacturer commissioned Home Delivery Service.
Delivery: Scotland
Documents
Unlock document linkGlatiramer Injection
Not provided
The Framework Agreement is awarded for the supply of Glatiramer Acetate Injection in 20 mg and 40 mg presentations to Participating Authorities across NHS. Scotland. Supply will be made either directly to hospitals, patients in their own ho...
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.